MAPK1 and hepatocellular carcinoma: Network pharmacology analysis predicted that the molecular targets highly associated with the common signaling pathways including MAPK1, PIK3CA, EGFR, CCND1, and NFKBIA may be related with the antitumor effects of ZJP on HCC in regulating HCC cell proliferation and survival.